CN Patent

CN115768779A — 伊曲康唑前药及其用途

Assigned to Shanghai Qiyi Pharmaceutical Technology Co ltd · Expires 2023-03-07 · 3y expired

What this patent protects

本发明涉及伊曲康唑前药，包含该前药的药物组合物，以及使用该药物组合物治疗和/或预防肺纤维化、肾纤维化或肝脏纤维化的方法。

USPTO Abstract

本发明涉及伊曲康唑前药，包含该前药的药物组合物，以及使用该药物组合物治疗和/或预防肺纤维化、肾纤维化或肝脏纤维化的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN115768779A
Jurisdiction
CN
Classification
—
Expires
2023-03-07
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Qiyi Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.